CATALOGO DEI PRODOTTI DELLA RICERCA

ORSOLINI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.608
EU - Europa 2.223
AS - Asia 1.967
SA - Sud America 262
AF - Africa 30
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.562
CN - Cina 790
SG - Singapore 716
GB - Regno Unito 590
IT - Italia 303
DE - Germania 260
RU - Federazione Russa 239
BR - Brasile 228
SE - Svezia 212
HK - Hong Kong 200
FR - Francia 199
IE - Irlanda 185
FI - Finlandia 99
IN - India 57
KR - Corea 53
JP - Giappone 43
UA - Ucraina 32
VN - Vietnam 31
CA - Canada 24
AT - Austria 23
BE - Belgio 17
TR - Turchia 14
MX - Messico 12
NL - Olanda 12
PL - Polonia 12
ES - Italia 11
AR - Argentina 10
BD - Bangladesh 10
ZA - Sudafrica 10
TG - Togo 9
ID - Indonesia 7
IR - Iran 7
VE - Venezuela 7
CL - Cile 6
UZ - Uzbekistan 6
AU - Australia 5
IQ - Iraq 5
RO - Romania 5
CZ - Repubblica Ceca 4
GR - Grecia 4
MA - Marocco 4
AZ - Azerbaigian 3
CO - Colombia 3
EC - Ecuador 3
KG - Kirghizistan 3
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
MK - Macedonia 2
NP - Nepal 2
PY - Paraguay 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CH - Svizzera 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
MW - Malawi 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PF - Polinesia Francese 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.100
Salva come PNG Salva come JPEG
Città #
Southend 555
Chandler 478
Dallas 354
Singapore 337
Hong Kong 198
Dublin 185
Ashburn 159
Jacksonville 136
Redmond 134
Beijing 130
Ann Arbor 94
New York 76
Bologna 70
Lawrence 70
Princeton 70
Wilmington 68
Woodbridge 66
Helsinki 54
Shenyang 54
Munich 53
Jinan 50
Nanjing 44
Verona 44
Tokyo 40
Hebei 34
Houston 31
Sindelfingen 30
Tianjin 29
Los Angeles 27
Milan 27
Zhengzhou 26
Haikou 25
Ningbo 25
Hangzhou 24
Changsha 23
Columbus 21
Taiyuan 20
Guangzhou 19
Hyderabad 19
São Paulo 19
The Dalles 19
Seattle 18
Vienna 17
Brussels 16
Washington 16
Nanchang 15
Turku 15
Brooklyn 14
Norwalk 14
Redwood City 14
San Francisco 14
Taizhou 14
Jiaxing 13
Moscow 13
Santa Clara 12
Venice 12
Chicago 11
Dong Ket 11
Fuzhou 11
Fairfield 10
Denver 9
Lomé 9
Rio de Janeiro 8
Jakarta 7
Johannesburg 7
Kent 7
Mexico City 7
Seoul 7
Warsaw 7
Atlanta 6
Boardman 6
Boston 6
Cagliari 6
Chennai 6
Düsseldorf 6
Falkenstein 6
Falls Church 6
Frankfurt am Main 6
London 6
Shanghai 6
Tashkent 6
Toronto 6
Belo Horizonte 5
Campinas 5
Charlotte 5
Dearborn 5
Lanzhou 5
Lappeenranta 5
Naples 5
Nürnberg 5
Rome 5
Barcelona 4
Bari 4
Brasília 4
Cambridge 4
Dhaka 4
Dongguan 4
Goiânia 4
Ho Chi Minh City 4
Manchester 4
Totale 4.424
Salva come PNG Salva come JPEG
Nome #
Artrite Reumatoide e Metabolismo Minerale 197
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 168
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 155
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 148
Anti-CCP antibodies and bone 142
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 140
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 137
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 134
Osteoporosis treatment: why ibandronic acid? 125
Bone involvement and osteoporosis in mastocytosis. 125
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 124
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 123
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 118
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 115
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 113
Bone Disease in Mastocytosis 111
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 110
BIOMARKERS LABORATORISTICI RELATIVI AL COINVOLGIMENTO OSSEO NELLE ARTROPATIE INFIAMMATORIE 110
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 108
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 106
Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. 104
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 103
Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece? 103
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 102
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 102
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 102
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 101
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 101
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 100
Rheumatoid arthritis, γδ T cells and bisphosphonates 98
Association between environmental air pollution and rheumatoid arthritis flares 98
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 96
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 94
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 94
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 94
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 92
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 92
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 90
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 90
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 89
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 89
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 87
Osteoporosis in Rheumatic Diseases 85
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 85
Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study 84
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 83
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 81
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 81
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 78
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 77
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 77
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 76
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 75
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 75
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 73
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 73
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 72
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 71
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 69
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 68
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 67
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 64
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 63
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 62
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 60
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 57
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 55
Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis 54
Changes in bone turnover markers and bone modulators during abatacept treatment 53
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 53
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 52
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 49
Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus 48
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 47
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 47
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 46
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 43
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 41
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 41
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement 40
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 34
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 33
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 27
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 27
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 10
Totale 7.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.150
article - articoli 30.798
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 352
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021505 0 0 24 130 102 53 28 8 44 3 68 45
2021/2022602 56 166 10 40 23 8 19 27 58 10 40 145
2022/20231.332 83 147 105 246 120 311 18 66 167 11 46 12
2023/2024757 32 60 70 90 77 146 30 40 13 26 134 39
2024/20251.710 82 103 77 285 90 50 76 68 265 152 140 322
2025/2026892 368 286 238 0 0 0 0 0 0 0 0 0
Totale 7.286